SynthesisBMC women's health2025
Hysteropexy for stage 1 uterine prolapse to prevent recurrence: a systematic review and Dutch nationwide survey.
Synthesis in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundIt is generally considered that women start experiencing bothersome complaints when a pelvic organ prolapse reaches stage 2. However, studies indicate that a stage 1 uterine prolapse can already cause symptoms and consensus on its treatment is lacking. The aim of this study is to identify the available literature and the clinical variance regarding concomitant surgical treatment for stage 1 uterine prolapse during surgical treatment for stage ≥ 2 anterior and/or posterior prolapse and to assess its effect on the risk of recurrence.
methodPubMed and Cochrane CENTRAL library were searched in July 2025. Studies reporting recurrence after surgical prolapse repair for stage ≥ 2 anterior and/or posterior compartment prolapse with or without concomitant hysteropexy for stage 1 uterine prolapse were included. Simultaneously, a survey regarding the clinical practice on surgical treatment of stage 1 uterine prolapse was set out to gynecologists in The Netherlands.
resultsA total of 1416 records were retrieved. After screening, 16 records remained for full review. None of these studies reported the outcomes in the group of interest (i.e., stage 1 uterine prolapse). Corresponding authors were contacted for additional information on this subgroup. Three articles were included, one article performing and two not performing concomitant hysteropexy (e.g. Manchester Fothergill or Sacrospinous Hysteropexy). Reported recurrence rates were 18% in the group with concomitant hysteropexy and 20 and 60% in the groups without concomitant hysteropexy.
conclusionThis systematic review shows that literature on stage 1 uterine prolapse repair is lacking. The survey shows large clinical variance in the treatment approach of stage 1 uterine prolapse. A prospective study on the effectiveness of concomitant hysteropexy for stage 1 uterine prolapse is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.